Indefinite Delivery Contract 75D30126D21001
Award Date 6/1/26
Last Date to Order 5/31/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- Pfizer Inc. was awarded a multiple-award Indefinite Delivery/Indefinite Quantity contract valued at $2.21 billion by the Centers for Disease Control and Prevention (CDC) to supply pediatric vaccines for the Vaccines for Children (VFC) program. The contract period runs from April 1, 2025, through March 31, 2026, with no set-aside designation. Under this solicitation, Pfizer will manufacture and deliver standard commercial pediatric vaccines meeting FDA licensing requirements and maintaining a...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc. for the procurement of standard commercial COVID-19 vaccines with a pediatric indication for children aged 0 through 18 years. The contract has a $1,075,250,000.00 ceiling value and a performance period ending on June 6, 2024. The vaccines procured under this multiple-award IDC will support pediatric immunization programs through the Vaccines...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Pfizer Inc. on June 1, 2026, with a ceiling value of $505,272,000 for FDA-approved COVID-19 vaccines for adults aged 19 and older under Executive Order 14398. No set-aside applies. The contract supports the CDC's Section 317 immunization program, which distributes vaccines to state and local health departments across all fifty states, several large city programs, and U.S. Territories. Place of...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. as the prime contractor. The contract has a ceiling value of $1,517,947,500.00 and a period of performance from April 1, 2022 through March 31, 2023. It is a multiple award contract vehicle that will provide up to 23 standard pediatric vaccines to support CDC's Immunization Awardees and the Vaccines for...
- Sanofi Vaccines US Inc., a division of Sanofi Pasteur Inc., was awarded a multiple-award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) to supply pediatric influenza vaccines for the Vaccines for Children (VFC) program. The contract, issued on December 31, 2025, carries a ceiling value of $337.4 million and extends through February 28, 2027. The VFC program, established under the Omnibus Budget Reconciliation Act of 1993, provides vaccines to eligible...
- This Indefinite Delivery/Indefinite Quantity (ID/IQ) contract, awarded to Pfizer Inc. on June 1, 2024, establishes a multiple-award vehicle for the procurement of COVID-19 pediatric vaccines with a ceiling value of $1.097 billion. The contract is funded by the Centers for Disease Control and Prevention (CDC) Pittsburgh and will remain in effect through September 30, 2025. As a civilian agency contract with no small business set-aside designation, this award reflects Pfizer's status as a large,...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to provide a range of standard pediatric vaccines to support immunization programs under the Vaccines for Children (VFC) program and Section 317(j) of the Public Health Service Act. The $1.6 billion multiple-award IDC has a period of performance from April 1, 2021 through March 31, 2022, with no small business set-asides utilized. The...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Moderna US, Inc. on June 1, 2026, with a ceiling of $285,044,250 and an ultimate completion date of May 31, 2027. This is an unrestricted procurement carrying no set-aside designation. Place of performance is centered in Chamblee, Georgia, with delivery to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky for refrigerated and frozen vaccines, or as...
- The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under the Vaccines for Children 2021 program to support pediatric immunization efforts. The contracts hold a potential value of $1.039 billion and were awarded to Glaxosmithkline, LLC for the period of April 1, 2021 through March 31, 2022. The contracts will provide 20 standard pediatric vaccines to the CDC's Immunization Awardees for distribution through the Vaccines for Children program and Section...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, to procure a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The contract has a ceiling value of $1,914,795,500.00 and a period of performance from April 1, 2024 through March 31, 2025. The solicitation sought offers for 27 different pediatric vaccines including vaccines for diseases such as dengue, diphtheria,...